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Introduction {#sec1}
============

Neural stem cells (NSCs) resident in the two main neurogenic niches of the adult mammalian brain (the subventricular zone \[SVZ\] of the lateral ventricle and the subgranular zone of the hippocampal dentate gyrus \[DG\]) are two heterogeneous populations of radial glia-like precursor cells that have astrocytic properties, express bona fide stem cell markers and rarely divide. These cells have the capacity to self-renew and differentiate, giving rise to both neurons and glia (reviewed in [@bib9], [@bib31]). The mechanisms of fate determination in adult hippocampal NSC (aNSC) lineage is a highly debated topic ([@bib8], [@bib30]) and of fundamental importance. In addition, understanding the molecular mechanisms underlying lineage determination might provide new avenues to prevent age-dependent loss of neurogenesis ([@bib21], [@bib40], [@bib44]), or the pathological generation of undesirable cells such as activated glia upon trauma and epilepsy ([@bib19], [@bib20], [@bib51], [@bib54]).

Regulation of aNSC fate determination is known to be possible at the transcriptional level ([@bib7]), but accumulating evidence indicates that additional control layers, such as epigenetics and non-coding RNAs, are involved in this mechanism ([@bib14], [@bib15], [@bib28], [@bib35], [@bib43], [@bib47]). MicroRNAs (miRNAs) are small (∼22 nt long) single-stranded non-coding RNAs, which post-transcriptionally repress target mRNAs through imperfect miRNA-mRNA binding ([@bib1], [@bib26], [@bib34]). They exert their regulatory functions in a highly combinatorial way: one miRNA can regulate several mRNAs in parallel ([@bib36]), and different miRNAs can target one mRNA simultaneously, thus repressing its expression more efficiently ([@bib50]). Based on these observations, miRNAs are predicted to regulate the majority of mammalian mRNAs ([@bib23]).

Despite the known functions of miRNAs in fate determination of embryonic and adult SVZ NSCs ([@bib5], [@bib16], [@bib59]), as well as survival and dendritic maturation of adult-born neurons in the DG ([@bib32], [@bib39], [@bib48], [@bib55]), it has been unknown whether miRNAs regulate neuronal versus astrocyte lineage fate determination in the adult hippocampus. Indeed, as single miRNAs could have opposite effects depending on the spatiotemporal expression of their targets ([@bib60]), it is possible to hypothesize that the same miRNAs might exert different functions in various cell types involved in adult hippocampal neurogenesis.

Current approaches to infer miRNA functions in vivo either manipulate single miRNAs/targets or deplete miRNAs by conditional knockouts of genes encoding essential miRNA biogenesis proteins such as DROSHA, DGCR8, or DICER. Although both approaches successfully demonstrated critical functions for specific miRNAs and miRNA biogenesis proteins in neurogenesis ([@bib2], [@bib5], [@bib47]), most of these studies neglected the intrinsic combinatorial nature of miRNA-dependent control ([@bib46], [@bib53]), or left unresolved the question of miRNA-specific versus miRNA-independent functions of miRNA biogenesis proteins ([@bib57]).

By conditional ablation of *Dicer* specifically in bona fide aNSCs of the adult hippocampus in vivo and in vitro and by manipulation of specific miRNAs, here we studied the role of miRNAs for lineage fate choice of aNSCs. Our study identified a set of 11 miRNAs that, by synergistic enforcement of gene-regulatory networks, allows aNSCs to acquire the neurogenic fate at the expense of astrogliogenesis.

Results {#sec2}
=======

Split-Cre Virus-Mediated *Dicer* Ablation In Vivo Impairs Neurogenesis, but Not Astrogliogenesis, in the Adult Hippocampus {#sec2.1}
--------------------------------------------------------------------------------------------------------------------------

To study the role of DICER in adult hippocampal neurogenesis in vivo, we first crossed a mouse line carrying a conditional allele for *Dicer* (*Dicer*^flox^, [@bib41]) with a Cre-inducible reporter mouse line (Td-Tomato^flox^, [@bib38]). To achieve conditional ablation of *Dicer* and expression of Tomato in bona fide type 1 aNSCs, we injected split-Cre viruses (allowing specific expression of an active Cre recombinase in type 1 aNSCs, based on the coincident activity of human glial fibrillary acidic protein \[hGFAP\] and Prominin1 promoters) ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A; [@bib6]) in the DG of 8-week-old *Dicer*^wt/wt^ Td-Tomato^flox/wt^ (wild-type; WT), *Dicer*^*f*lox/wt^ Td-Tomato^flox/wt^ (Dicer HT), and *Dicer*^flox/flox^ Td-Tomato^flox/wt^ (Dicer cKO) mice, and followed the fate of the labeled cells in the subgranular zone (SGZ) and granule cell layer (GCL) of the hippocampus.

To ascertain *Dicer* ablation in vivo, we sorted Tomato^+^ cells by fluorescence-activated cell sorting (FACS) and, as internal control non-infected Tomato^−^ cells, from the DG of WT and *Dicer* cKO mice, and quantified *Dicer* mRNA levels by quantitative real-time PCR (qRT-PCR). This quantification confirmed a 70% reduction of *Dicer* mRNA levels in Tomato^+^ cells from *Dicer* cKO mice, compared with Tomato^+^ cells from WT mice ([Figure 1](#fig1){ref-type="fig"}B, p = 0.0001) and Tomato^−^ cells from both WT and *Dicer* cKO mice ([Figure 1](#fig1){ref-type="fig"}B, p = 0.003).

To investigate the survival of the progeny originating from the *Dicer* cKO aNSCs at 1 month after virus injection, we administered bromodeoxyuridine (BrdU) for 5 consecutive days. Ten days or 1 month after BrdU, we quantified the proportion of Tomato/BrdU double-positive cells in the SGZ/GCL of WT, *Dicer* HT, and cKO mice ([Figure 1](#fig1){ref-type="fig"}A). The proportion of Tomato/BrdU double-positive cells in *Dicer* cKO and *Dicer* HT mice showed a slight increase at 10 days ([Figure 1](#fig1){ref-type="fig"}D), but significantly decreased in *Dicer* cKO mice at 1 month ([Figures 1](#fig1){ref-type="fig"}C and 1D, p = 0.006). This result indicated that *Dicer* depletion impaired survival of newborn cells in the SGZ/GCL.

Moreover, we also observed a dramatic reduction in the number of processes and arborization of Tomato^+^ *Dicer* cKO cells in the GCL and molecular layer (ML) of the hippocampus compared with Tomato^+^ WT cells ([Figure 1](#fig1){ref-type="fig"}C). This finding suggested that *Dicer* depletion impaired the differentiation and maturation of the surviving cells.

Next, we assessed the role of DICER in neuronal fate choice. We quantified the proportion of newborn cells co-expressing the immature neuronal marker doublecortin (DCX) or postmitotic neuronal marker NeuN in the SGZ/GCL of the adult hippocampus of *Dicer* WT, HT, and cKO mice (as in [Figure 1](#fig1){ref-type="fig"}A). At 10 days we did not find differences in DCX and NeuN expression among the groups ([Figures 1](#fig1){ref-type="fig"}F and 1G). However, at 1 month we found that 40% of *Dicer* WT cells also co-expressed DCX, whereas only 26% of *Dicer* HT cells and 10% of *Dicer* cKO cells did so, respectively ([Figure 1](#fig1){ref-type="fig"}G, WT versus KO, p = 0.0012; WT versus HT, p = 0.039). Consistently, at the same age, only 20% of *Dicer* cKO cells co-expressed NeuN, compared with 60% of NeuN^+^ *Dicer* WT neurons ([Figures 1](#fig1){ref-type="fig"}E and 1F, p = 0.0058). Moreover, although the proportion of newborn NeuN^+^ neurons increased significantly between 10 days and 1 month in the SGZ/GCL of *Dicer* WT mice ([Figures 1](#fig1){ref-type="fig"}E and 1F, p = 0.0062), this population did not grow over time in *Dicer* cKO mice (p = 0.72). These results indicate that *Dicer* depletion impairs neuronal differentiation and maturation in the adult mouse hippocampus in vivo.

We then assessed the role of DICER on adult astrogliogenesis by immunostaining for three different astrocyte markers, GFAP, S100b ([Figure 1](#fig1){ref-type="fig"}E), and glutamine synthetase (GS; [Figure S1](#mmc1){ref-type="supplementary-material"}B) and found results complementary to the findings on neurogenesis. Whereas no significant differences were observed for S100b at 10 days between the three *Dicer* genotypes; at 1 month the proportion of S100b^+^ ([Figure 1](#fig1){ref-type="fig"}H, p = 0.0002) and GS^+^ ([Figure S1](#mmc1){ref-type="supplementary-material"}C, p = 0.024) was about twice as high in the SGZ/GCL of *Dicer* cKO mice than in controls. Moreover, upon *Dicer* ablation we did not observe an increase in progenitor markers such as Nestin or SOX2 ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C), largely excluding the possibility that *Dicer* cKO cells remained in undifferentiated or quiescent state. Thus, these results indicated that *Dicer* depletion in type 1 aNSCs impaired neurogenesis and favored astrogliogenesis in the adult hippocampus in vivo.

Loss of DICER-Dependent miRNAs Does Not Affect aNSC Proliferation and Stemness, but Increases Apoptosis upon Their Differentiation In Vitro {#sec2.2}
-------------------------------------------------------------------------------------------------------------------------------------------

To ascertain the effect of *Dicer* ablation in vitro, we generated primary aNSCs from the DG of mice WT, HT, and homozygous for *Dicer*^*flox*^ allele, which were also heterozygous for the Cre-inducible Td-Tomato allele, by culturing them in monolayers ([Figure S1](#mmc1){ref-type="supplementary-material"}D) as described previously ([@bib4], [@bib56]). Upon recombination of *Dicer*^*flox*^ locus ([Figure 2](#fig2){ref-type="fig"}B) and expression of Tomato protein ([Figure 2](#fig2){ref-type="fig"}A), we saw a 50% reduction of *Dicer* transcript in *Dicer* HT aNSCs ([Figure 2](#fig2){ref-type="fig"}C, p = 0.0082) and almost total loss in *Dicer* cKO aNSCs ([Figure 2](#fig2){ref-type="fig"}C, p = 0.0003) compared with WT. Consequently, mature miRNAs levels were reduced to 50% in *Dicer* HT aNSCs ([Figure 2](#fig2){ref-type="fig"}D, p = 0.01) and almost completely depleted in *Dicer* cKO aNSCs ([Figure 2](#fig2){ref-type="fig"}D, residual miRNA levels 7%; p \< 0.0001), compared with WT cells. These results demonstrated that recombination of the *Dicer*^flox^ allele resulted in efficient depletion of both *Dicer* transcript and mature miRNAs from hippocampal aNSCs in vitro. Despite efficient loss of DICER-dependent miRNAs, we were able to keep *Dicer* cKO aNSCs in culture under proliferative conditions for at least 18 days in vitro (DIV). We did not detect major differences in cell morphology or passaging requirements for cells from the three genotypes. Moreover, no differences were observed in the percentage of Tomato^+^ cells incorporating BrdU after a 2-hr pulse ([Figures S2](#mmc1){ref-type="supplementary-material"}A--S2C and S2G--S2I), or pH3 ([Figures S2](#mmc1){ref-type="supplementary-material"}D and S2E). Consistently, the growth curve was unchanged over several days in culture ([Figure S2](#mmc1){ref-type="supplementary-material"}F). Thus, we concluded that loss of DICER-dependent miRNAs does not affect aNSCs proliferation.

Next, we investigated stem cell markers SOX2, GFAP, and Nestin in aNSCs, and found no change in SOX2 or GFAP expression at both protein and transcript levels in aNSCs from the three genotypes ([Figure S3](#mmc1){ref-type="supplementary-material"}). However, consistent with our in vivo results ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C), we detected reduced expression of Nestin in *Dicer* cKO aNSCs compared with WT aNSCs ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3C, p = 0.0021; [Figure S3](#mmc1){ref-type="supplementary-material"}D, WT versus cKO p = 0.0053; HT versus cKO p = 0.03). Altogether, these results confirmed that loss of DICER-dependent miRNAs did not primarily affect proliferation, passaging requirements, and expression of stem cell markers of aNSCs. These results are consistent with previous studies on other stem cells types ([@bib41]) including embryonic NSCs ([@bib3], [@bib18]), reporting that the effects of *Dicer* ablation are more prominent during cell fate transitions than in self-renewal.

Our data indicated that *Dicer* ablation impairs survival of newborn neurons in vivo ([Figure 1](#fig1){ref-type="fig"}). Thus we investigated the survival of aNSCs from *Dicer* WT, HT, and cKO upon induction of differentiation. Recombined (Tomato^+^) *Dicer* WT, HT, and cKO aNSCs were FACS sorted, and equal numbers of aNSCs were seeded and cultivated under differentiating conditions ([Figure S4](#mmc1){ref-type="supplementary-material"}A). After 6 DIV we found a 30% and 50% reduction in the number of *Dicer* HT and *Dicer* cKO aNSCs compared with WT aNSCs ([Figures S4](#mmc1){ref-type="supplementary-material"}B and S4C, WT versus cKO, p = 0.03). Moreover, the reduced survival of *Dicer* cKO aNSCs was paralleled by a significant increase in the number of pycnotic nuclei ([Figures S4](#mmc1){ref-type="supplementary-material"}B and S4C, p = 0.0051), expression of the apoptotic marker active-caspase-3 ([Figures S4](#mmc1){ref-type="supplementary-material"}B and S4C, p = 0.013), and reduction in the expression of the transcript of anti-apoptotic protein Bcl-2 ([Figure S4](#mmc1){ref-type="supplementary-material"}D, p = 0.04). Thus, consistently with in vivo data ([Figure 1](#fig1){ref-type="fig"}), these results indicated that DICER functions are not essential for expansion of aNSCs in vitro, but are required for survival of their progeny.

Loss of DICER-Dependent miRNAs Impairs Neurogenesis but Not Astrogliogenesis In Vitro {#sec2.3}
-------------------------------------------------------------------------------------

Our in vivo data suggested that *Dicer* depletion in aNSCs impairs neurogenesis but not astrogliogenesis in the adult mouse hippocampus ([Figure 1](#fig1){ref-type="fig"}). Thus, we isolated recombined (Tomato^+^) *Dicer* WT, HT, and cKO aNSCs and investigated neurogenesis and neuronal maturation upon differentiation in vitro ([Figure 3](#fig3){ref-type="fig"}A). We found that *Dicer* HT and cKO aNSCs generated significantly fewer DCX^+^ cells compared with WT aNSCs ([Figures 3](#fig3){ref-type="fig"}B and 3C, DCX^+^ ∼12% in *Dicer* HT, p = 0.04; ∼9% in *Dicer* cKO, p = 0.0013). Moreover, we saw a reduction in the number of neurites, branch points, and dendritic spines in DCX^+^ *Dicer* cKO cells compared with *Dicer* WT and HT cells ([Figure 3](#fig3){ref-type="fig"}D).

Next, we investigated astrogliogenesis in recombined (Tomato^+^) *Dicer* WT, HT, and cKO aNSCs upon differentiation (as in [Figure 3](#fig3){ref-type="fig"}A) and found no difference between the three *Dicer* genotypes ([Figure 6](#fig6){ref-type="fig"}B). We then induced astrocyte differentiation with 10% fetal serum for 6 DIV ([Figure 4](#fig4){ref-type="fig"}A) and found no difference in the proportion of cells expressing astrocytic markers GFAP and S100b between groups ([Figures 4](#fig4){ref-type="fig"}B and 4C). These data were corroborated by a parallel decrease in the expression of the bona fide stem cell marker Nestin, at both mRNA and protein levels ([Figures 4](#fig4){ref-type="fig"}D--4H), and by a strong increase in the expression of astrocytic markers GFAP and S100b ([Figures 4](#fig4){ref-type="fig"}E, 4F, and 4I) in all genotypes. These results were consistent with our in vivo evidence ([Figure 1](#fig1){ref-type="fig"}) and indicated that DICER functions are essential for aNSC differentiation toward neurogenesis and neuronal maturation but not for astrogliogenesis.

A Pool of 11 miRNAs Determines aNSC Neurogenic Fate at the Expense of Astrogliogenesis {#sec2.4}
--------------------------------------------------------------------------------------

To clarify whether DICER-dependent miRNAs or additional RNAi-related functions of DICER are involved in the control of adult hippocampal neurogenesis, we first analyzed the dynamics of miRNA expression in WT aNSCs under proliferating conditions, as well as upon the induction of neuronal differentiation with virally transmitted ASCL1 expression at 7, 14, and 21 DIV ([Figure 5](#fig5){ref-type="fig"}A; [@bib10]). This approach increased the proportion of MAP2^+^ neurons to 95% ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B). By qRT-PCR we detected 335 mature miRNAs in these cells. These miRNAs could be classified into three groups according to the levels and dynamics of their expression during proliferation, early neuronal differentiation (7 DIV), and late neuronal differentiation (14 and 21 DIV) ([Figure 5](#fig5){ref-type="fig"}B). As expected, miRNAs known to be involved in proliferation or in neuronal differentiation were dynamically regulated ([Figures S5](#mmc1){ref-type="supplementary-material"}C and S5D; [@bib47]), thus supporting the validity of our approach.

We hypothesized that miRNAs, whose expression is associated with early steps of neuronal fate choice, might rescue a DICER-dependent impairment on neurogenesis. We focused on a group of 11 miRNAs that showed a preferential enrichment (fold change log \>2) and high levels of expression (\<25 Ct values) during early neuronal differentiation (7 DIV): miR-376b-3p, 139-5p, 218-5p, 411-5p, 127-3p, 134-5p, 370-3p, 135a-5p, 382-5p, 708-5p, and 124-3p ([Figure 5](#fig5){ref-type="fig"}B, higher magnification; [Figures 5](#fig5){ref-type="fig"}C and [S5](#mmc1){ref-type="supplementary-material"}E). To validate these miRNAs in vivo, we performed qRT-PCR analysis of total RNA from Tomato^+^ cells that were FACS sorted 2 months after split-Cre infection of adult WT or *Dicer* cKO mice. We could detect most of these miRNAs in Tomato^+^ WT cells as well as their significant reduction in *Dicer* cKO ([Figure 5](#fig5){ref-type="fig"}D). Next, we transfected in vitro WT and *Dicer* cKO aNSCs with control miRNAs, or *Dicer* cKO cells with a pool containing the 11 miRNAs (here referred as "total pool"). Six days after transfection, we found that the total pool, but not control miRNAs, rescued DICER-dependent impairment of neurogenesis to WT levels, as indicated by the expression of neuronal markers DCX ([Figures 6](#fig6){ref-type="fig"}A and 6B, p = 0.012; [Figure 6](#fig6){ref-type="fig"}E for mRNA quantification, p = 0.03) and MAP2 ([Figures 6](#fig6){ref-type="fig"}A and 6B, p = 0.0001). Moreover, we found a concomitant decrease in astrocytic differentiation from *Dicer* cKO aNSCs 6 days after transfection with the total pool, as revealed by a reduced expression of S100b ([Figures 6](#fig6){ref-type="fig"}A and 6B, p = 0.003) and *GFAP* mRNA ([Figure 6](#fig6){ref-type="fig"}E, p = 0.0019), indicating that these miRNAs were sufficient to control the switch between neuronal and astrocyte fates. Remarkably, when administered individually, or in subpools (chosen by the number of shared predicted targets involved in astrogliogenesis or neurogenesis, [Table S2](#mmc1){ref-type="supplementary-material"} and see below), we did not rescue neurogenesis impairment in *Dicer* cKO aNSCs ([Figures 6](#fig6){ref-type="fig"}C, 6E, and [S6](#mmc1){ref-type="supplementary-material"}A). To further trim down the pool, we tested the withdrawal of individual miRNAs from the total pool in *Dicer* cKO aNSCs and found that none of them rescued neurogenesis impairment ([Figure 6](#fig6){ref-type="fig"}D). These experiments indicate that all of the 11 miRNAs are sufficient to rescue neuronal commitment in miRNA-depleted aNSCs.

To further ascertain whether these miRNAs are required, we conducted the opposite experiment by transfecting 11 miRNA inhibitors into WT aNSCs. We found a significant reduction in DCX^+^ cells ([Figures 7](#fig7){ref-type="fig"}A and 7B, p = 0.003) and MAP2^+^ cells ([Figures 7](#fig7){ref-type="fig"}A and 7B, p = 0.0025), but an increase in S100b^+^ cells ([Figures 7](#fig7){ref-type="fig"}A and 7B, p = 0.05) compared with control WT cells. Taken together, these results demonstrate that 11 miRNAs are sufficient and required to sustain neuronal fate determination in hippocampal aNSCs, at the expense of astrogliogenesis, presumably through a synergic action.

Dissecting Pathways and Potential Targets Modulated by the 11 miRNAs in aNSCs {#sec2.5}
-----------------------------------------------------------------------------

We hypothesized that the 11 miRNAs might synergize to simultaneously suppress pro-gliogenic and anti-neurogenic target genes. Consistently with this hypothesis, upon transfection of total miRNA pool (but not subpools), we found a significant reduction of the expression of negative regulators of neuronal differentiation, such as *SP1* (p = 0.048), or astrocyte differentiation such as *Tgfbr1* (p = 0.0002) ([Figure S6](#mmc1){ref-type="supplementary-material"}B).

To further dissect potential targets and pathways modulated by the 11 miRNAs in aNSCs, we performed shotgun proteomics analysis in WT aNSCs transfected with the 11 miRNA inhibitors or control RNA and cultured them for 6 days in differentiating conditions. As expected, upon inhibition of 11 miRNAs we observed more upregulated proteins (\>1.5-fold = 419; [Figure 7](#fig7){ref-type="fig"}C) than downregulated (\<0.5-fold = 63; [Figure 7](#fig7){ref-type="fig"}C), compared with control inhibitors. Of interest, proteins dysregulated upon miRNA inhibition in aNSCs were enriched for metabolism (gene ontology \[GO\]: 44237; 59.8%, p = 2.5e-4) or cell cycle (GO: 7049; 16%, p=1.5e-5) processes, several of them, such as DRP2 (4.1 ± 0.5), NVL (1.53 ± 0.17), CNOT4 (12.66 ± 0.00), PTBP1 (1.63 ± 0.6), TLE1 (1.83 ± 0.6), and SFXN5 (1.64 ± 0.42) being highly expressed in astrocytes ([@bib13], [@bib58]) and predicted to be targeted by at least one of the 11 miRNA subjects of our study.

Next, we performed an in silico analysis to identify potential targets for the 11 miRNAs ([Tables S1](#mmc2){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}). We used miRWalk 2.0 with highly restrictive parameters, and found that a substantial fraction of the predicted targets (37%, i.e., 1,817 out of 4,929) were shared by at least two of the 11 miRNAs ([Table S1](#mmc2){ref-type="supplementary-material"}) and had previously been shown to be expressed in developing astrocytes or neurons ([@bib13]) ([Figure S7](#mmc1){ref-type="supplementary-material"}).

To provide a molecular mechanism supporting the idea that synergic action of the 11 miRNAs is both necessary and sufficient to sustain adult neurogenesis, we compared the dysregulated proteins upon miRNA inhibition ([Figure 7](#fig7){ref-type="fig"}C) with the predicted targets ([Table S1](#mmc2){ref-type="supplementary-material"}) and found 26 proteins of interest ([Figure 7](#fig7){ref-type="fig"}D). Remarkably, none of them was a predicted target of all miRNAs. Instead, they were predicted targets of different combinations of the selected miRNAs ([Figure 7](#fig7){ref-type="fig"}E). Moreover, based on analyses with DAVID ([@bib29]) or Reactome ([@bib22]) software, we did not find any pathway that was shared between the 26 candidates. In contrast, GO analysis revealed that the 26 proteins shared similar biological processes ([Figure 7](#fig7){ref-type="fig"}F), such as nervous system development (GO: 7399; 30%, p = 0.011), neurogenesis (GO: 22008; 27%, p = 0.011), and neuron differentiation (GO: 30182; 24%, p = 0.023).

These results suggested that the 11 miRNAs cooperate by acting upon several targets within different pathways in parallel to determine adult neurogenesis.

Discussion {#sec3}
==========

Our study demonstrates that a set of 11 miRNAs (of which nine were not previously characterized in adult neurogenesis) is essential for neurogenic lineage fate determination of aNSCs in the adult hippocampus, and does so at the expense of astrogliogenesis. Remarkably, these miRNAs could rescue impaired neurogenesis in *Dicer* cKO aNSCs to WT levels only when administered as a pool, not individually. Thus our study provides evidence for the emerging notion of miRNA "convergence" (or "cooperativity") that, by synergistic enforcement of gene-regulatory networks, allows the acquisition of neurogenic fate programming in aNSCs.

Adult neurogenesis is a highly conserved process among vertebrates ([@bib24]). However, the mechanisms underlying the control of a proper acquisition of the neurogenic versus astrogliogenic fate remains a fundamental question in the field ([@bib8], [@bib30]). Here, by targeting bona fide type I aNSCs in vivo and in vitro, we show that loss of DICER-dependent miRNAs in aNSCs impaired neurogenesis but not astrogliogenesis. Thus our results uncover miRNAs as a regulatory level necessary to sustain neurogenic lineage and prevent astrogliogenesis in the adult hippocampal niche. This evidence reinforces the emerging idea that multiple layers of control are required to allow adult neurogenesis to occur properly. This has recently been demonstrated for other epigenetic mechanisms in a similar way ([@bib37], [@bib43]).

An interesting question is why, given these results, DICER/miRNA-depleted aNSCs can still undergo astrocytic differentiation at all? Based on our results, and given the proposed glial nature of aNSCs ([@bib11], [@bib33], [@bib42]), which share common molecular pathways with non-neurogenic astrocytes ([@bib6], [@bib12], [@bib17]), we postulate that the gliogenic program in aNSCs might represent rather a "default" developmental path than a fate change, and thus be less dependent on miRNAs ([@bib21]). Despite we cannot rule out that "immature or intermediate" astrocytes are generated by *Dicer*-depleted aNSCs in vivo, these newborn cells (as revealed by Td-Tomato and BrdU) were also positive for different astrocytic markers, such as S100b ([Figures 1](#fig1){ref-type="fig"}E and 1H) and GS ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C) 2 months after *Dicer* deletion. Moreover, since upon *Dicer* ablation we did not find increased expression of progenitor markers such as Nestin or SOX2 ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C), we postulate that these cells might be bona fide astrocytes, rather than aNSCs remaining in undifferentiated (or returning) or quiescent state. Another possibility is that miRNA-depleted newborn neurons could be more susceptible to apoptosis compared with astrocytes. However, differentiating aNSC *Dicer* HT ([Figure 2](#fig2){ref-type="fig"}) were not more susceptible than WT cells to apoptosis ([Figure S4](#mmc1){ref-type="supplementary-material"}), but still gave rise to fewer neurons ([Figure 3](#fig3){ref-type="fig"}). This suggests that miRNA loss in aNSCs can affect the switch toward neurogenesis independently from cell death. Finally, it is still possible that different subtypes of neural and glial progenitor cells exist in the adult hippocampal niche that responds differently to miRNA depletion; hence in the absence of Dicer/miRNAs neurogenesis fails while astrogliogenesis is proportionally increased. This scenario would be consistent with the known heterogeneity of aNSCs ([@bib52]). However, we can still conclude that loss of *Dicer* and DICER-dependent miRNAs does not impair astrogliogenesis in the adult hippocampal stem cell niche.

Although, due to limitations of the current tools and technical challenges, we could not perform direct manipulation of the 11 miRNAs to rescue/inhibit neurogenesis in vivo, we demonstrated that most of these miRNAs are expressed in adult-born hippocampal neurons, and consequently depleted upon the loss of *Dicer* in vivo. Moreover, our in vitro experiments identify that all of the 11 miRNAs are sufficient to rescue DICER-dependent impairment of neurogenesis ([Figure 6](#fig6){ref-type="fig"}) and are required to sustain neurogenesis in WT aNSCs ([Figure 7](#fig7){ref-type="fig"}). Together, these results strongly indicate that miRNAs, rather than other additional DICER functions, determine neuronal fate of aNSCs. In perspective, our approach might be a useful paradigm to functionally investigate other miRNAs and targets. For example, 6 of the 11 miRNAs of our study are encoded by the *Dlk1-Dio3* imprinted genomic region, containing the mirG locus that is highly enriched with miRNAs and deregulated in neurodevelopmental disorders and brain tumors ([@bib25], [@bib27]). This locus also encodes miR-134, which is important for neuronal synaptogenesis and plasticity ([@bib49]).

The proposed synergy of miRNA actions refers to the "convergence" or "cooperativity" of miRNAs as a rapidly emerging theme in neurobiology, and has recently been proposed for embryonic neurogenesis ([@bib5]), the adult SVZ ([@bib45]), and apoptosis in the adult DG ([@bib48]). Consistent with this idea, we identified 26 putative targets of the 11 miRNAs that did not share immediate involvement in any pathway, but synergistically regulate biological processes such as neurogenesis, nervous system development, and neuronal differentiation. These results are consistent with our model whereby miRNAs "converge on function" ([@bib5]). Given that each of the 11 miRNAs individually did not significantly induce neurogenesis, the synergic action on several targets from different pathways in parallel might compensate for the mild degree of miRNA-dependent regulation of individual mRNA targets. Further studies will be essential to experimentally validate the miRNAs and targets that are, in combination, key in regulating aNSCs neurogenesis.

Finally, the identification of a set of miRNAs that determines neuronal fate of aNSCs raises interesting perspectives with regard to age-dependent loss of hippocampal neurogenesis ([@bib40]) or the generation of undesirable cells upon insults or cell transplantation ([@bib19], [@bib20], [@bib51], [@bib54]). Perhaps administration of the miRNAs that were the subject of this study will increase our repertoire of approaches to sustain neurogenesis in the aging brain, or to improve efficiency of NSC-based regenerative therapies.

Experimental Procedures {#sec4}
=======================

Animals {#sec4.1}
-------

Mice were housed under standard laboratory conditions at Istituto Italiano di Tecnologia (IIT). All experiments and procedures were approved by the Italian authorities (permit nos. 056/2013 and 214/2015-PR) and were conducted in accordance with the Guide for the Care and Use of Laboratory Animals of the European Community Council Directives. *Dicer*^*flox/flox*^ mice ([@bib41]) were crossed with *Td-Tomato*^*flox/wt*^ knockin reporter mice (Jackson Laboratory stock number 007908; [@bib38]). *Dicer*^*wt/wt*^ *Td-Tomato*^*flox/wt*^ (*Dicer* WT), *Dicer*^*flox/wt*^ *Td-Tomato*^*flox/wt*^ (*Dicer* HT), and *Dicer*^*flox/flox*^ *Td-Tomato*^*flox/wt*^ (*Dicer* cKO) were used for experiments.

aNSC Preparation, Culture Conditions, and miRNA Administration {#sec4.2}
--------------------------------------------------------------

Hippocampal NSCs were prepared and expanded as described previously ([@bib4], [@bib56]). *Dicer* ablation was obtained in proliferating aNSCs by nucleofection (Amaxa, Lonza) of 5 μg of Cre recombinase-expressing vector under the control of constitutive cytomegalovirus enhancer/chicken β-actin (CAG) promoter (pCAGGS-CRE). Detailed cell-culture protocols are described in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. For miRNA administration, proliferating aNSCs were nucleofected (Amaxa, Lonza) with a pool of mimics or antagomirs at equimolar concentration to a final concentration 250 nM (Dharmacon, negative control, CN-001000-01-05); or with a mix of individual miRNA mimics each at 25 nM, plus negative control to a final concentration of 250 nM. Twenty-four hours after nucleofection, cells were plated in differentiation medium and harvested after 6 days.

Immunofluorescence {#sec4.3}
------------------

Immunofluorescence staining on brain slices was performed in one of every six sections of the hippocampus. A list of primary antibodies and detailed protocol are provided in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. Images were obtained with the Confocal A1 Nikon Inverted SFC with 40× objective. Quantification and analysis in the DG was performed using NIS-Elements software (Nikon). Immunofluorescence on cell cultures was performed as previously described ([@bib4]). Images were obtained using the microscope Nikon Eclipse at 20× or 40× magnification, and cell-counter plugin in ImageJ software (Macbiophotonics) was used to keep track of counted cells.

RNA/Protein Extraction, Analysis, and Proteomics {#sec4.4}
------------------------------------------------

For RNA extraction and cDNA preparation, six to ten mice (each Dicer genotype) were euthanized at the indicated time points. DG cells were dissociated with the Neural Tissue Dissociation Kit P (Miltenyi Biotec), and FACS-sorted cells were immediately processed for RNA extraction. Cre-nucleofected aNSCs in culture were harvested at the indicated time points. Total RNA was extracted with QIAzol protocol (Qiagen) and RNA purified with RNeasy Mini Kit, or miRNeasy Mini Kit (Qiagen) following the manufacturer\'s instructions. cDNA (for mRNAs) synthesis was obtained with ImProm-II reverse transcriptase (Promega); cDNA (from miRNA) was prepared with an miScript II RT kit using the HiSpec Buffer (Qiagen) according to the manufacturer\'s instructions. mRNA was quantified with a QuantiFast SYBR Green PCR Kit (Qiagen) on a ABI-7500 Real-Time PCR System (Applied Biosystems). Each sample was normalized to *GAPDH* or *Actin* levels. Specific primers used for gene expression analysis are listed in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. miRNAs were quantified with the Mouse Cell Differentiation & Development miScript miRNA PCR Array (Qiagen) and miScript SYBR Green PCR kit (Qiagen) following the manufacturer\'s recommendations on an ABI-7500 Real-Time PCR System (Applied Biosystems) or with TaqMan Array Rodent MicroRNA A Cards Set v3.0 (Thermo Fisher) following the manufacturer\'s recommendations with a ViiA 7 Real-Time PCR system (Thermo Fisher), for which original Ct values are available on request. For western blotting, proteins were extracted from aNSCs by RIPA buffer containing protease inhibitors (Complete mini EDTA-free, Roche), separated by SDS-PAGE on a 10% Tris gradient gel and transferred to a nitrocellulose membrane (Bio-Rad). Membranes were probed overnight using primary antibodies: rabbit GFAP (1:5,000; catalog no. Z-0334, Dako), rat anti-NESTIN (1:1,000; 556309, BD-Pharmingen), rabbit GAPDH (1:4500; AM4300, Applied Biosystems), and secondary horseradish peroxidase-conjugated antibodies (1:2,500; anti-rabbit immunoglobulin G \[IgG\], A16074, Life Technologies; anti-rat IgG, 31470, Thermo Fisher). Bands were detected by ECL (Millipore) using ImageQuant LAS 4000 Mini (GE Healthcare) and quantified using ImageJ software.

For proteomics, aNSCs (three independent experiments) were lysed with RIPA buffer and 60 μg of proteins was collected from all the samples to isobarically label them using TMT Sixplex kits (Thermo Fisher Scientific). Protein pools were processed for liquid chromatography-tandem mass spectrometry analysis (see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}).

Statistical Analysis {#sec4.5}
--------------------

Data are presented as mean ± SEM and were analyzed using Prism 6 (GraphPad). Statistical significance was assessed with a two-tailed unpaired t test for two experimental groups. For experiments with three or more groups, one-way ANOVA with Bonferroni\'s multiple comparison test as post hoc was used. Results were considered significant when p \< 0.05.
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![Split-Cre Virus-Mediated *Dicer* Ablation In Vivo Impairs Neuronal Differentiation and Survival but Not Astrogliogenesis\
(A) Schematic representation of the experiment.\
(B) qRT-PCR quantification of *Dicer* mRNA from FACS-sorted Td-Tomato^+^ aNSCs 2 months after split-Cre virus injection.\
(C and E) Representative micrographs showing recombined Td-Tomato/BrdU double-positive cells from *Dicer* WT and *c*KO mice 1 month after BrdU injection (C), co-expressing NeuN (E, left panel), GFAP (E, middle panel) and S100b (E, right panel). Yellow arrowheads show Td-Tomato/BrdU double-positive cells co-expressing NeuN, GFAP, or S100b.\
(D) Percentage of Td-Tomato^+^ cells expressing BrdU after 10 days, or 1 month after BrdU injections.\
(F--H) Percentage of Td-Tomato/BrdU double-positive cells co-expressing NeuN (F), DCX (G), or S100b (H) 10 days or 1 month after BrdU injections.\
ML, molecular layer; GCL, granular cell layer; SGZ, subgranular zone; H, Hilus. Data are expressed as mean ± SEM, n = 4--6 mice per group. Unpaired t test was used for Dicer mRNA expression analysis. One-way ANOVA Bonferroni as post hoc was used to analyze cell marker quantification. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. Scale bars, 20 μm.](gr1){#fig1}

![*Dicer* and miRNAs Are Depleted after Recombination of *Dicer*^flox^ Allele in Hippocampal aNSCs In Vitro\
(A) Representative micrographs showing Td-Tomato^+^ aNSCs from *Dicer* WT, *Dicer* HT, and *Dicer* cKO mice after nucleofection with Cre recombinase.\
(B) PCR Genotyping of Cre-recombined aNSCs, showing the three *Dicer* genotypes.\
(C) qRT-PCR quantification of *Dicer* mRNA in Cre-recombined aNSCs.\
(D) Average of all miRNAs quantified from recombined aNSCs.\
Data are expressed as mean ± SEM, n = 3 independent experiments containing three replicates. One-way ANOVA Bonferroni as post hoc: ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. Scale bar, 50 μm.](gr2){#fig2}

![Loss of *Dicer*-Dependent miRNA in aNSCs Impairs Neurogenesis and Neuronal Maturation In Vitro\
(A) Schematic representation of the protocol and experiment.\
(B) Representative micrographs showing recombined Td-Tomato^+^ aNSCs from *Dicer* WT, *Dicer* HT, and *Dicer* cKO mice after 6 DIV with growth factors titration expressing DCX.\
(C) Percentage of Td-Tomato^+^ cells expressing DCX.\
(D) Representative micrographs showing dendritic morphology of immature newly formed neurons expressing DCX.\
Data are expressed as mean ± SEM, n = 3 independent experiments containing three replicates. One-way ANOVA Bonferroni as post hoc: ^∗^p \< 0.05, ^∗∗∗^p \< 0.001. Scale bars, 50 μm.](gr3){#fig3}

![Loss of *Dicer*-Dependent miRNAs Does Not Affect Astrogliogenesis of aNSCs In Vitro\
(A) Schematic representation of the protocol and experiment.\
(B) Representative micrographs showing recombined Td-Tomato^+^ aNSCs from *Dicer* WT, *Dicer* HT, and *Dicer* cKO mice after 6 DIV with 10% fetal bovine serum expressing S100b (upper panels) and GFAP (bottom panels).\
(C) Percentage of Td-Tomato^+^ cells expressing astrocyte markers (GFAP and S100b).\
(D--F) Relative *Nestin* (D), *GFAP* (E), and *S100b* (F) mRNA quantification with qRT-PCR.\
(G--I) Protein quantification of NESTIN (H) and GFAP (I).\
Data are expressed as mean ± SEM, n = 3 independent experiments containing three replicates. One-way ANOVA Bonferroni as post hoc: ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. Scale bar, 50 μm.](gr4){#fig4}

![Profiling of miRNA Expression during Neuronal Differentiation of aNSCs In Vitro\
(A) Schematic representation of the neuronal differentiation protocol with inducible retrovirus expressing ASCL1 (*Ascl1-ERT2-IRES-GFP*) and the experiment. Cells were collected during proliferation (P) or differentiation after 7 (D7), 14 (D14), and 21 (D21) DIV.\
(B) Heatmap representing the set of miRNAs dynamically regulated upon neuronal differentiation at 7, 14, and 21 DIV. Red indicates high expression and green, low expression.\
(C) Fold change of selected miRNAs during differentiation over proliferating cells.\
(D) Fold change expression of miRNAs in vivo in FACS-sorted Td-Tomato^+^ cells from ten adult *Dicer* WT and ten *Dicer* cKO mice 2 months after split-Cre recombinase virus injection into the DG. n = 3 independent experiments containing three replicates.\
Data are expressed as mean ± SEM. Paired t test: ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.](gr5){#fig5}

![A Pool of 11 miRNAs Synergistically Rescues *Dicer* cKO Impairment of Adult Neurogenesis, at the Expense of Astrogliogenesis, In Vitro\
(A) Representative micrographs showing aNSCs from *Dicer* WT and *Dicer* cKO mice transfected with 250 nM scrambled RNA or total pool (25 nM of each miRNA) after 6 DIV of growth factors withdrawal expressing DCX (upper panel), MAP2 (middle panel), and S100b (bottom panel). Scale bar, 50 μm.\
(B) Percentage of DCX-, MAP2-, and S100b-positive aNSCs with respect to DAPI in WT and KO aNSCs transfected with scrambled RNA or total pool.\
(C) Proportion of KO aNSCs expressing DCX upon transfection of 250 nM subpool 1 (mir-124-3p + mir-135a-5p), subpool 2 (mir-139-5p + mir-218-5p + mir-411-5p + mir-134-5p + mir-370-3p + mir-382-5p + mir-708-5p), subpool 3 (mir-127-3p + miR-376b-3p), or each miRNA alone with respect to KO control.\
(D) Percentage of DCX-positive aNSCs with respect to DAPI after 6 DIV from WT or KO mice transfected with scrambled RNA, total pool, or a pool with ten miRNAs by the withdrawal of individual miRNAs.\
(E) mRNA quantification with qRT-PCR from recombined KO aNSCs after 6 DIV.\
Data are expressed as mean ± SEM, n ≥ 3 independent experiments containing three replicates. One-way ANOVA with Bonferroni as post hoc test: ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.](gr6){#fig6}

![Convergence of the 11 miRNAs on Neurogenesis-Related Biological Processes\
(A) Representative micrographs showing aNSCs from *Dicer* WT mice transfected with 250 nM scrambled RNA or a pool of miRNA inhibitors (antagomir) (25 nM of each miRNA inhibitor) after 6 DIV of growth factor withdrawal expressing DCX (upper panel), MAP2 (middle panel), and S100b (bottom panel).\
(B) Percentage of DCX-, MAP2-, and S100b-positive aNSCs with respect to DAPI in WT aNSCs transfected with scrambled RNA or pool inhibitor.\
(C) Expression proteomics profile of miRNA inhibitor with respect to control group at 6 DIV.\
(D) Venn diagram showing the putative predicted targets by at least two miRNAs from the in silico analysis that are significantly dysregulated in the proteomics analysis upon miRNA inhibitor administration.\
(E) Dysregulated proteins that are putatively targeted by at least two miRNAs. Fold change and SD for WT aNSCs transfected with a pool of inhibitors versus control RNA for each protein expression and predicted targeting miRNAs are shown. A.C, absent in control samples; A.I, absent in miRNA inhibitor samples.\
(F) Gene ontology (GO) analysis significantly represented for the 26 predicted common targets dysregulated upon miRNA inhibition.\
Data are expressed as mean ± SEM, n = 3 independent experiments containing three replicates. Unpaired t test: ^∗^p \< 0.05, ^∗∗^p \< 0.01. Scale bar, 50 μm.](gr7){#fig7}
